Call for Letters of Interest

American College of Rheumatology Seeks Letters of Interest from Potential Guideline Development Partners

The ACR invites letters of interest from those who wish to partner with ACR to develop new clinical practice guidelines for the prevention and treatment of juvenile idiopathic arthritis (specifically systemic JIA, oligoarticular JIA, and immunizations) and lupus nephritis. The guidelines will be developed primarily for rheumatologists who care for patients with these diseases, but may also be used by primary care providers and others who care for these patients.

Please submit your letter of interest by email to the contact below by November 30, 2018. In addition, please email an electronic version of the final letter of interest.

ACR Practice Guideline Subcommittee
c/o Regina Parker
American College of Rheumatology
2200 Lake Boulevard NE
Atlanta, GA 30319
rparker@rheumatology.org

ACR will not review letters of interest that are not in electronic format.

Guideline Project Information

See details about the JIA call for letters of interest

See details about the Lupus Nephritis call for letters of interest

Coming Soon - Extrarenal Lupus

The ACR intends to call for interested lupus experts to participate in an ACR lupus guideline project in late 2019. The majority (at least 51%) of the confirmed guideline development team will need to have had no conflicts of interest, i.e., relationships with companies that have a commercial interest in lupus. Relationships with these companies that would constitute COI would include serving as a principal investigator (PI) or site PI of industry-supported research studies (even for non-lupus related products, if the company also has an interest in lupus), for at least the previous 12 months and continuing throughout the duration of the project. The proposed PI and literature review leader for the ACR lupus guideline project must be unconflicted. Interested experts and/or possible teams are encouraged to consider their COI status now in order to be prepared to apply for this opportunity in late 2019. The ACR encourages proposed investigators with any commercial interests to inquire as to whether these constitute a conflict (contact aturner@rheumatology.org).